Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Informatics » Lynx Therapeutics Inks SNP Collaboration with Oxagen

Lynx Therapeutics Inks SNP Collaboration with Oxagen

Jun 03, 1999
Premium

HAYWARD, Calif.--Lynx Therapeutics announced that it will collaborate with Oxagen of Oxford, UK, to discover and validate disease-associated single-nucleotide polymorphisms (SNPs). The program will initially focus on inflammatory bowel disease, but may be extended to other common disorders. No financial terms were disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Not Going With Verily

Kaiser Health News reports San Francisco and Alameda counties in California are no longer using Verily Life Sciences' COVID-19 testing program.

From Bread Bakery to Lab Space

The New York Times reports that developers in New York City are increasingly interested in life science spaces.

Decline in Antibodies

A UK study has found that antibodies against SARS-CoV-2 may decline over time, Reuters reports.

PNAS Papers on Diabetic Kidney Disease, Spontaneous Diploid Yeast Mutations, More

In PNAS this week: genetic and epigenetic variation in individuals with diabetic kidney disease, spontaneous genetic alterations in Saccharomyces cerevisiae, and more.

Oct
28
Featured Webinar

How Low Can You Go? Reduce Breeding Costs with an Optimized Genotyping and Analysis Strategy

Sponsored by
NRGene

Molecular breeding methods such as genomic selection and genome-wide association studies often require high-density genotypic data from many samples, but the cost and complexity of genotyping at this scale may be prohibitive.

Oct
29
Featured Webinar

How to Train Your DRAGEN for Pathology Informatics

Sponsored by
Illumina

Illumina’s BaseSpace Sequence Hub (BSSH) supports primary and secondary analysis of massively parallel sequencing data and can be applied to gene panel data that is generated as part of a clinical cancer assay performed in a pathology lab.

Nov
09
Featured Webinar

The Tumor Neighborhood Watch: How Spatial Architecture and Cellular Neighborhoods Correlate to Colorectal Cancer Outcomes

Sponsored by
Akoya Biosciences

Most recent single-cell and spatial biology studies have focused on the network of interactions between different cell types and their spatial context. 

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Informatics

  1. Roche, Fabric Genomics Ink Comarketing Agreement for Whole-Exome Sequencing Solution

  2. Eagle Genomics Raises $9M

  3. Caris Life Sciences Raises $310M Through Equity, Debt Financing

  4. GoodCell Raises $17.9M for Analytics Technology, Personal Biobanking

  5. ICBiome Bets on Whole-Genome Sequencing Analysis to Control MRSA, COVID-19 Outbreaks

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.